Thilo J. Zander

Thilo J. Zander is currently the Chief Scientific Officer at Dayton Therapeutics, a position held since June 2020. Concurrently, Thilo J. Zander serves as a Medical Oncologist and Head of the Lymphoma and Myeloma Service at Luzerner Kantonsspital, a role undertaken since March 2011. With significant expertise in oncology and leadership in scientific research, Thilo J. Zander contributes to advancements in the treatment of lymphatic and myeloma conditions.